Prediction of Diltiazem Plasma Concentration Curves From Limited Measurements Using Compliance Data

Clinical Pharmacokinetics

Volumn 22, Issue 3, 1992, Pages 238-246

  Rubio, Ana ^a,b   Cox, Christopher ^a   Weintraub, Michael ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; METHODOLOGY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; SICKLE CELL CRISIS;

ANEMIA, SICKLE CELL; CASE REPORT; DILTIAZEM; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; MALE; PREDICTIVE VALUE OF TESTS; SUPPORT, NON-U.S. GOV'T;

EID: 0026564552     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/00003088-199222030-00006     Document Type: Article

References (13)

1. The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose
2. Pharmacokinetics of diltiazem and its metabolites after repeated multiple-dose treatments in healthy volunteers
3. Pharmacokinetics of diltiazem and its metabolites after repeated single dosing in healthy volunteers
4. Pharmacokinetics of diltiazem and its metabolites after single and multiple dosing in healthy volunteers
5. Improving drug dosing in hospitalized patients: automated modelling of pharmacokinetics for individualization of drug dosage regimens
6. Population pharmacokinetics
7. Time to stop counting the tablets?
8. Fitting pharmacokinetic models with BMDPAR
9. The natural history of medication compliance in a drug trial: limitations of pill counts
10. Medication monitor/dispenser for pharmacological and compliance research
11. Pharmacokinetic and pharmacodynamic effects of diltiazem
12. Capricious compliance and intelligent noncompliance
13. Compliance data: the next level